Contribute Try STAT+ Today

G’morning to ya! Nicholas St. Fleur here to fill in for Ed following this Labor Day weekend. I must admit, I don’t have any flamboyant coffee flavors to share this morning. My cup of joe of choice is always a medium roast straight from my mom’s Keurig. I take it black and top it off with room-temperature water because I like to drink my coffee fast and I can’t do that if it’s scorching hot. Sorry it’s not more exciting. But what is exciting is the lineup of pharma news we’ve got to share with you to give your morning a boost. …

A major hurdle stands in the way of the development of new vaccines, as well as the critical studies needed to determine the best way to use these important tools, the Coalition for Epidemic Preparedness Innovations (CEPI) warned in a letter published Tuesday in the journal Nature, STAT writes. Part of the problem is that testing new vaccines against placebos is unethical at this point, and testing them against the vaccines that are already widely used is tough because they are in such high demand globally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment